Clinical Research
Thermo Fisher Scientific Expands Access To Structural Biology With Glacios 3 Cryo TEM
Equipped with the READY System to make structural biology research accessible to more labs Thermo Fisher Scientific, the world leader in serving science, ...
April 01, 2026 | News
Hengrui Pharma And Braveheart Bio Report Strong Phase 2 Results For HRS 1893 In Obstructive Hypertrophic Cardiomyopathy
Results of dose-ranging study suggest potential for best-in-class clinical profile across efficacy, safety and ease of use, including s...
April 01, 2026 | News
Centivax Secures 37 Million Dollars In Oversubscribed Financing To Advance Universal Influenza Vaccine
Centivax, Inc., a clinical-stage biotechnology company engineering vaccines and therapies for durable, universal protection against highly diverse targets,...
April 01, 2026 | News
Matricelf And CiRA Foundation Partner To Advance Scalable iPSC Based Neural Tissue Manufacturing
Matricelf Ltd. (TASE: MTLF), a biotechnology company developing a novel autologous engineered neural tissue therapy for patients with spinal cord injury, a...
March 31, 2026 | News
Neurophet Partners With ALZ NET To Advance AI Driven Imaging In Alzheimer’s Care
Aims to improve quality of care for patients with Alzheimer's disease… Exploring adoption of Neurophet's key solutions Collaboration expected to ...
March 31, 2026 | News
Anumana Secures FDA Clearance For AI Algorithm Enabling Early Detection Of Pulmonary Hypertension
Anumana, a leader in cardiovascular AI, has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its pulmonary hypertension (PH) algorithm...
March 30, 2026 | News
Clarity Pharmaceuticals Signs Copper 64 Supply Agreement With Theragenics To Advance Radiopharmaceutical Commercialisation
Clarity Pharmaceuticals (ASX: CU6) ("Clarity" or "Company"), a clinical-stage radiopharmaceutical company with a mission to develop next-generation pr...
March 27, 2026 | News
Hope Medicine Initiates Phase III Trial Of HMI 115 For Endometriosis
Hope Medicine Inc., a science-driven, clinical-stage innovative biopharmaceutical company, announced that the first patient has been dosed in the Phase III...
March 26, 2026 | News
Akeso Advances IO 2.0 Plus ADC 2.0 Strategy With Phase II Trial Clearance In China
Akeso, Inc. (9926.HK) ("Akeso" or the "Company") announced that it has received clearance from the Center for Drug Evaluation (CDE) of China's ...
March 26, 2026 | News
BrightGene Reports Positive Phase 1 Results For Oral GLP 1 GIP Agonist BGM0504
BGM0504 shown to be generally well tolerated Overall safety, pk, and efficacy profile supports once-daily oral dosing BrightGene Bio-Medical Technology C...
March 26, 2026 | News
Thermo Fisher Accelerates Clinical Intelligence Leadership With Strategic Clario Acquisition
Further strengthens Thermo Fisher’s position as the trusted partner to pharma and biotech customers, delivering important customer benefits Attracti...
March 25, 2026 | News
Alphamab Oncology Initiates Phase III Study Of Anbenitamab In HER2 Positive Breast Cancer
Alphamab Oncology announced that the first patient has been dosed in the Phase III clinical study (KN026-007) of HER2 bispecific antibody Anbenitamab (KN02...
March 25, 2026 | News
Monash University And ClinChoice Partner To Accelerate Early Phase Clinical Trials
Monash University and ClinChoice Inc, a leading global clinical Contract Research Organization (CRO) focused on innovative therapeutics, announced a strate...
March 23, 2026 | News
ImmunityBio Secures Macau Approval For ANKTIVA In BCG Unresponsive Non Muscle Invasive Bladder Cancer
Macau SAR, China regulator grants approval for ANKTIVA® (nogapendekin alfa inbakicept-pmln) in patients with BCG-unresponsive NMIBC with CIS &plusm...
March 23, 2026 | News
Most Read
- How Does GLP-1 Work?
- Innovations In Magnetic Resonance Imaging Introduced By United Imaging
- Management of Relapsed/Refractory Multiple Myeloma
- 2025 Drug Approvals, Decoded: What Every Biopharma Leader Needs to Know
- BioPharma Manufacturing Resilience: Lessons From Capacity Expansion and Supply Chain Resets from 2025
- APAC Biopharma Review 2025: Innovation, Investment, and Influence on the Global Stage
- Top 25 Biotech Innovations Redefining Health And Planet In 2025
- The New AI Gold Rush: Western Pharma’s Billion-Dollar Bet on Chinese Biotech
- Single-Use Systems Are Rewiring Biopharma Manufacturing
- The State of Biotech and Life Science Jobs in Asia Pacific – 2025
- Asia-Pacific Leads the Charge: Latest Global BioSupplier Technologies of 2025
- Invisible Threats, Visible Risks: How the Nitrosamine Crisis Reshaped Asia’s Pharmaceutical Quality Landscape
Bio Jobs
- Sanofi Turns The Page As Belén Garijo Steps In And Paul Hudson Steps Out
- Global Survey Reveals Nearly 40% of Employees Facing Fertility Challenges Consider Leaving Their Jobs
- BioMed X and AbbVie Begin Global Search for Bold Neuroscience Talent To Decode the Biology of Anhedonia
- Thermo Fisher Expands Bengaluru R&D Centre to Advance Antibody Innovation and Strengthen India’s Life Sciences Ecosystem
- Accord Plasma (Intas Group) Acquires Prothya Biosolutions to Expand Global Plasma Capabilities
- ACG Announces $200 Million Investment to Establish First U.S. Capsule Manufacturing Facility in Atlanta
- AstraZeneca Invests $4.5 Billion to Build Advanced Manufacturing Facility in Virginia, Expanding U.S. Medicine Production
News
